Review of 120 pts w/ Catastrophic antiphospholipid syndrome showed that 54% had skin involvement & was 1st APS sx in 35%. Findings: livedo racemosa (45%), necrosis/ulcers (42%), splinter hemorrhages (29%), distal edema (23%), purpura (14%). https://t.co/zFsPUdo4Wb https://t.co/rEN4yfoP9h

• https://bit.ly/3VBV84K

Sparks editorial -- RA pathogenesis has been linked to pollution, Lung Dz, smoking, silica dust, asbestos, textile dust, brick/concrete laying, pesticides, military burn pits - some w/ strong associ w/ HLA-SE and ACPA, but not ACPA-negative RA https://t.co/ZStmF8MeLD https://t.co/xQxJ74aQ81

• https://bit.ly/3Phy4G7

SLE: Variability in Racial Disparities in Pregnancy Outcomes Significant disparities exist in pregnancy outcomes in women with SLE, w/previous cohorts identifying Black women as having a higher risk of maternal mortality compared to White women w/SLE. https://t.co/1PrJYpMcHx https://t.co/YN7K0Gf5Jl

• https://bit.ly/3HjoHDU

Tapering Methotrexate with Biologics or JAK Inhibitors in RA Dr Segan ( @JulianSegan) discusses Abstract 0916 at #ACR22. https://t.co/CUjZ7SiSoE https://t.co/VYtmCIJEt6

• https://bit.ly/3uvQfhL

Lifestyle Modifications may enhance TNF Inhibitors in axSpA https://t.co/0O4jd3g0WL https://t.co/zUaRUR9tGL

• https://bit.ly/3P6TeXg

The Top 10 Research Priorities in Psoriatic Arthritis A survey of 317 carers and clinicians focused on psoriatic arthritis has set an agenda of the top 10 research questions for psoriatic arthritis (PsA). https://t.co/zfivHvtLX9 https://t.co/LZsiE417w2

• https://bit.ly/3Y4BAYn

Multi-ancestry analysis reveals novel genetic loci associated with OA https://t.co/AIo3il8uHP https://t.co/nXGtOCCZsA

• https://bit.ly/3h0DFnK

Systematic review comparing MIS-C and Kawasaki: 14 studies, 2928 pts; major differences- KD pts were younger; MIS-C had more Pulm, GI, Shock, more cardiac (LV, valvular pericarditis, myocarditis), but less coronary lesions & conjunctivitis https://t.co/bcCRh5HxL7 https://t.co/qLvfCYwx9u

• https://bit.ly/3HjBK8u

Comparing Biosimilar Growth in the US, Germany, and Switzerland The biosimilar landscape will change dramatically in 2023, following the successful rollouts in other countries in Europe. https://t.co/LYcG0BNO6C https://t.co/V2m8HoIWLF

• https://bit.ly/3iNFzbS

GCA: What we feel and what we can't Dr. David Liew ( @drdavidliew) discusses Abstracts 0483 and 0486 at #ACR22 Convergence. https://t.co/Pobsb2anLa https://t.co/RQS4N3TqgK

• https://bit.ly/3Y2X5Ja

Timely Fetal Screening Important in Positive Anti-Ro Antibody Pregnancies Dr. Yusof ( @Yuz6Yusof) discusses Abstract 0957 presented at #ACR22. https://t.co/yl4K7jZMGr https://t.co/6733AEhRyX

• https://bit.ly/3P7HwvG

Imaging in PMR One of the major limitations of PMR management is the lack of a gold standard investigation or biomarker of disease activity. https://t.co/sZtgWKAtFv https://t.co/4H4tAY6CIZ

• https://bit.ly/3YgKP8b